Literature DB >> 25118661

Effect of DTPP-mediated photodynamic therapy on cell morphology, viability, cell cycle, and cytotoxicity in a murine lung adenocarcinoma cell line.

Jianhua Liu1, Liqing Zheng, Yingxin Li, Zhihua Zhang, Li Zhang, Lixia Shen, Xiulong Zhang, Haixia Qiao.   

Abstract

Photodynamic therapy (PDT) involves the administration and activation of photosensitizing reagents in cancer tissues to induce cytotoxicity. Here we examined the effects of 5-5- (4-N, N-diacetoxylphenyl)-10,15,20- tetraphenylporphyrin (DTPP) -mediated PDT on cell morphology, viability, cell cycle, and cytotoxicity in a murine lung adenocarcinoma cell line. LA795 murine lung adenocarcinoma cell line was used in the study, with cellular uptake of DTPP being quantified by a UV-visible spectrophotometer. The subcellular localization of DTPP was detected by confocal laser scanning microscopy, alteration of cell morphology after PDT was observed by an inverted light microscope, and late-stage apoptosis was examined by terminal dUTP nick end labeling (TUNEL) . The effects of influencing factors on cytotoxicity of PDT in LA795 cells was investigated with varying concentrations of DTPP, energy densities, power densities, and antioxidants by 3- (4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays. Effects of PDT on cell cycle and plasma membrane integrity were studied by flow cytometry analysis. The uptake of DTPP by LA795 cells reached maximum after incubation for 24 h. Confocal laser scanning microscopy showed that DTPP was mainly in the mitochondrion, and slight localization was detected in the lysosomes. Cellular inhibitory effects increased with increased irradiation dose and DTPP concentration, while unactivated DTPP had low toxicity. Flow cytometry analysis revealed that DTPP-PDT-treated cells showed S phase arrest. Cell membrane damage initiation, repair, and irreversible damage were observed at 2, 4, and 5 h after DTPP-PDT , respectively. Together, our results demonstrated cell apoptosis, compromised viability, and cell cycle S phase arrest of LA795 in response to DTPP-PDT , while no effect on the lung cancer cells was observed with irradiation or photosensitizer treatment alone.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25118661     DOI: 10.1007/s10103-014-1637-x

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  30 in total

1.  Photodynamic therapy for central nervous system tumours: achievements and prospects.

Authors:  P Marks
Journal:  Br J Neurosurg       Date:  1999-08       Impact factor: 1.596

Review 2.  Photodynamic therapy: mechanism of action and ways to improve the efficiency of treatment.

Authors:  Zivile Luksiene
Journal:  Medicina (Kaunas)       Date:  2003       Impact factor: 2.430

Review 3.  Oncologic photodynamic therapy photosensitizers: a clinical review.

Authors:  Ron R Allison; Claudio H Sibata
Journal:  Photodiagnosis Photodyn Ther       Date:  2010-04-21       Impact factor: 3.631

4.  Phthalocyanine-mediated photodynamic therapy induces cell death and a G0/G1 cell cycle arrest in cervical cancer cells.

Authors:  S L Haywood-Small; D I Vernon; J Griffiths; J Schofield; S B Brown
Journal:  Biochem Biophys Res Commun       Date:  2005-11-16       Impact factor: 3.575

Review 5.  Mitochondria-targeted antioxidants and metabolic modulators as pharmacological interventions to slow ageing.

Authors:  Jan Gruber; Sheng Fong; Ce-Belle Chen; Sialee Yoong; Giorgia Pastorin; Sebastian Schaffer; Irwin Cheah; Barry Halliwell
Journal:  Biotechnol Adv       Date:  2012-09-27       Impact factor: 14.227

6.  Functional consequences of sulfhydryl modification in the pore-forming subunits of cardiovascular Ca2+ and Na+ channels.

Authors:  N Chiamvimonvat; B O'Rourke; T J Kamp; R G Kallen; F Hofmann; V Flockerzi; E Marban
Journal:  Circ Res       Date:  1995-03       Impact factor: 17.367

7.  Effect of photodynamic therapy on recurrent pituitary adenomas: clinical phase I/II trial--an early report.

Authors:  P V Marks; P E Belchetz; A Saxena; U Igbaseimokumo; S Thomson; M Nelson; M R Stringer; J A Holroyd; S B Brown
Journal:  Br J Neurosurg       Date:  2000-08       Impact factor: 1.596

8.  Photodynamic tumor therapy: mitochondrial benzodiazepine receptors as a therapeutic target.

Authors:  A Verma; S L Facchina; D J Hirsch; S Y Song; L F Dillahey; J R Williams; S H Snyder
Journal:  Mol Med       Date:  1998-01       Impact factor: 6.354

9.  Enantiomer-specific profenofos-induced cytotoxicity and DNA damage mediated by oxidative stress in rat adrenal pheochromocytoma (PC12) cells.

Authors:  Xianting Lu; Cheng Yu
Journal:  J Appl Toxicol       Date:  2013-03-13       Impact factor: 3.446

Review 10.  Molecular effectors of multiple cell death pathways initiated by photodynamic therapy.

Authors:  Esther Buytaert; Michael Dewaele; Patrizia Agostinis
Journal:  Biochim Biophys Acta       Date:  2007-07-06
View more
  3 in total

1.  Application of Monolayer Cell Cultures for Investigating Basic Mechanisms of Photodynamic Therapy.

Authors:  Mans Broekgaarden
Journal:  Methods Mol Biol       Date:  2022

Review 2.  A review and outlook in the treatment of osteosarcoma and other deep tumors with photodynamic therapy: from basic to deep.

Authors:  Wei Yu; Jian Zhu; Yitian Wang; Junjie Wang; Weijing Fang; Kaishun Xia; Jianlin Shao; Minzu Wu; Bing Liu; Chengzhen Liang; Chengyi Ye; Huimin Tao
Journal:  Oncotarget       Date:  2017-06-13

Review 3.  BODIPYs in PDT: A Journey through the Most Interesting Molecules Produced in the Last 10 Years.

Authors:  Miryam Chiara Malacarne; Marzia Bruna Gariboldi; Enrico Caruso
Journal:  Int J Mol Sci       Date:  2022-09-05       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.